NanoViricides Inc. (NNVC)

[daBoze]

This is in response to Dr. Seymours request for ways to improve the PR's. It is not intended to be critical, just one man's take on communicating......

Nanoviricide, Inc (OTC-BB-NNVC) reported today that the latest animal studies for its Anti-HIV candidate (HivCide)produced results equivalent to the HAART three drug cocktail (highly active antiretroviral therapy) that is the currently favored treatment for HIV infected patients. The study was conducted by Kard Scientific, Inc. of Beverly, Massachusetts. The dosages for the NNVC candidate were administered eight times during the 48 day study as compared to daily dosages for the HAART cocktail.

Kard Scientifiic is the same laboratory that recently completed optimization studies for NNVC's FluCide candidate for influenza. Those studies reported a 1,000 times greater reduction in viral load in the bloodstream when compared to the current vaccine oseltamavir. NNVC believes that the same optimization process may provide similar improvements in its HivCide candidate. Such results could lead to a functional cure for HIV.


......and all that other stuff. eom